Logiscreen

ENDRA Life Sciences Inc

$4.23
Market Cap 5.25M
ROE -513.2%
Gross Margin 0.0%
Debt/Equity 0.5
Current Ratio 0.6
Revenue QoQ 0.0%
EPS QoQ -0.4%
F-Score 1

About

ENDRA Life Sciences is the pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS ® ), a ground-breaking technology being developed to assess tissue fat content and monitor tissue ablation during minimally invasive procedures, at the point of patient care. TAEUS ® is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools.

Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.81
vs median 33.61
P/B
3.31
vs median 2.16
ROE
-5.13
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics